Oncology Supportive Care

RyGen Biopharma develops biologic therapies designed to support patients undergoing cancer treatments such as chemotherapy. These therapies help strengthen the immune system and reduce treatment-related complications, enabling patients to better tolerate intensive cancer therapies.

Our oncology supportive care programs focus on biologics that help maintain healthy white blood cell levels and improve recovery during cancer treatment. Through advanced recombinant DNA technology and strong scientific expertise, RyGen aims to deliver safe, effective, and high-quality biologic solutions aligned with global healthcare standards.